Skip to content
10-Q

Quarterly Report

AMERICAN BIO MEDICA CORPORATION

0001654954-23-007911

← back to feed
Filed
Jun 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jun 12, 2023 48.1M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$363K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$13K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $68K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $34K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$458K
Stockholders Equity Q1 2023 · Dec 31, 2022 −$2.34M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$1.31M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$944K
Current Liabilities Q1 2023 · Mar 31, 2023 $1.12M
Current Liabilities Q1 2023 · Dec 31, 2022 $3.6M
Total Liabilities Q1 2023 · Mar 31, 2023 $1.12M
Total Liabilities Q1 2023 · Dec 31, 2022 $3.61M
Current Assets Q1 2023 · Mar 31, 2023 $659K
Current Assets Q1 2023 · Dec 31, 2022 $769K
Total Assets Q1 2023 · Mar 31, 2023 $659K
Total Assets Q1 2023 · Dec 31, 2022 $1.27M
Sga Expense Q1 2023 · Mar 31, 2023 $238K
Sga Expense Q1 2023 · Mar 31, 2022 $295K
Rd Expense Q1 2023 · Mar 31, 2023 $28K
Rd Expense Q1 2023 · Mar 31, 2022 $22K
Net Income Q1 2023 · Mar 31, 2023 $1.88M
Net Income Q1 2023 · Mar 31, 2022 −$379K
Operating Income Q1 2023 · Mar 31, 2023 −$212K
Operating Income Q1 2023 · Mar 31, 2022 −$331K
Gross Profit Q1 2023 · Mar 31, 2023 $74K
Gross Profit Q1 2023 · Mar 31, 2022 $28K
Cost Of Revenue Q1 2023 · Mar 31, 2023 $90K
Cost Of Revenue Q1 2023 · Mar 31, 2022 $323K
Revenue Q1 2023 · Mar 31, 2023 $164K
Revenue Q1 2023 · Mar 31, 2022 $351K